Orano USA, headquartered in Bethesda, Maryland, is a leading technology and services provider in the nuclear energy industry. They specialize in decommissioning shutdown nuclear energy facilities, managing used nuclear fuel, conducting federal site clean-up and closure, and the sale of uranium, conversion, and enrichment services to the U.S. commercial and federal markets.
In addition, Orano Med, a division of Orano, is at the forefront of research in nuclear medicine and is developing new radioisotopic therapies against cancer, utilizing the unique properties of lead-212. With their expertise and innovative solutions, Orano is committed to advancing the field of nuclear medicine and providing targeted therapies against cancer.
Generated from the website